Restructuring Clinical Trials to Find a Cure
Research!America and the Pancreatic Cancer Action Network held a meeting in New York this year to discuss ways to restructure clinical trials to find a cure for cancer.
Pfizer Patient Program becomes Pfizer RxPathways
As of April 01, 2014 All Pfizer Patient Assistance Programs have been consolidated into one program called Pfizer RxPathwaysTM.
Camp Kesem Provides a Week of Fun to Children of Cancer Patients
Approximately less than one minute into talking with Mariel and Terrance Pridmore, one thing became very clear—they cannot wait to go back to camp.
Complete Resection May Result in Long-Term GIST Survival
The results of a retrospective study indicated that patients with metastatic gastrointestinal stromal tumors (GIST) who are able to achieve complete macroscopic surgical resection of their disease may be able to achieve long-term survival.
LRG Appreciation Event brings together local supporters
In this spirit of appreciation, the Life Raft Group invited the local GIST community to a special dinner just to say thanks.
Life Insurance and Cancer
People around the world acquire life insurance policies for different reasons. It’s a common approach to protect one’s assets and cover debts should any life-changing circumstance occur, such as cancer.
GDOL Miami Attracts Large Attendance This Year
Over 80 GISTers and their loved ones gathered from all over to attend the 3rd annual GIST Day of Learning (GDOL) in Miami, held on February 9, to hear from the team of experts at University of Miami Sylvester Cancer Center.
Tissue Bank Update – Resistant Tissue is Scarce
In recent years we have been able to gain valuable information from the data produced by tissue donations to the GIST Collaborative Tissue Bank.
Indian Generic Drug Quality Questioned by FDA and U.S. Doctors
Indian generic drug quality has been questioned recently by a number of U.S. doctors. The concern stems from FDA recalls and import bans.
Trial Finds that Adjuvant Imatinib Impacts Recurrence-Free Survival
A recent clinical trial found that 1 year of adjuvant imatinib was able to increase recurrence-free survival. Keep reading to learn more.